Worldwide’s Scientific Solutions Team offers a suite of unique services with the singular goal of assuring endpoint quality to maximize trial sensitivity (i.e., the ability to detect drug: placebo differences) in clinical trials across therapeutic areas. These combined services are a direct response to increasing trial failure rates, heightened placebo response, and growing trial complexity.
Services are provided by Clinical Assessment Training and Surveillance, our in-house, long-established rater training and assessment offering whose overall objectives surround adhering to proper scale administration and scoring and continued surveillance methodologies to ensure accurate endpoint accrual throughout the life of the trial and Clinical Trial Liaison professionals who assist sites in a peer-to-peer fashion in enrolling the right subjects in a timely and efficient manner.
Together, these services align to achieve high-quality data and endpoint assurance to improve precision in trial planning and execution, minimize bias, and increase accuracy, empowering more confidence in study data. With a strong scientific focus on rigorous trial methodology, these services represent Worldwide’s promise for endpoint assurance and our pledge to provide valid, reliable, and high-quality data.
Learn more about the importance of qualified Clinical Trial Liaisons in our infographic, and read our latest article in Applied Clinical Trials.
